Clincosm LogoSign in Get a demo

carcinoma

Showing 1 - 25 of 189
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomical-Clinical Base of Adenocarcinoma Pancreatic

Recruiting
  • Adenocarcinoma
  • +2 more
  • collection of biological samples
  • Bordeaux, France
  • +7 more
Nov 20, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

Recruiting
  • Neoplasms
  • +12 more
  • Nanjing, Jiangsu, China
    Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
Oct 28, 2023

Carcinoma, Solid Tumor Trial in Suzhou (ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin)

Not yet recruiting
  • Carcinoma
  • Solid Tumor
  • ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin
  • Suzhou, China
    Second Affiliated Hospital of Soochow University
Oct 26, 2023

Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

Not yet recruiting
  • Carcinoma
  • +7 more
  • XNW5004
  • Pembrolizumab 25 mg/mL Solution for Injection
  • (no location specified)
Aug 31, 2023

Carcinoma Trial (Intravenous infusion anti-CEA-CAR-T cell)

Not yet recruiting
  • Carcinoma
  • Intravenous infusion anti-CEA-CAR-T cell
  • (no location specified)
Aug 22, 2023

Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +9 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Linyi, Shandong, China
    Linyi Central Hospital
Jul 25, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing

Recruiting
  • Carcinoma
  • +4 more
    • Nanjing, Jiangsu, China
      Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
    Jun 30, 2023

    Carcinoma, Upper Tract Urothelial Carcinoma, UTUC Trial in Nanjing (RC48-ADC and JS001)

    Recruiting
    • Carcinoma
    • +2 more
    • RC48-ADC and JS001
    • Nanjing, Jiangsu, China
      Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
    Jun 15, 2023

    Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)

    Recruiting
    • Carcinoma
    • +4 more
    • Guangzhou, Guangdong, China
      Lei Zhang
    Jun 21, 2023

    Carcinoma, Cervix Carcinoma Trial in Fuzhou (Karelizumab combined with etoposide and cisplatin)

    Not yet recruiting
    • Carcinoma
    • Cervix Carcinoma
    • Karelizumab combined with etoposide and cisplatin
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital
    Jun 9, 2023

    Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))

    Recruiting
    • Sarcoma
    • +8 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Shanghai, Jiangsu, China
      Xuzhou Second People's Hospital
    May 8, 2023

    Carcinoma, Carcinoma, Hepatocellular, Liver Tumor Trial in Spokane (99mTc-Macro Albumin Aggregate)

    Recruiting
    • Carcinoma
    • +2 more
    • 99mTc-Macro Albumin Aggregate
    • Spokane, Washington
      Inland Imaging
    May 4, 2023

    Carcinoma Trial in Taoyuan City

    Recruiting
    • Carcinoma
      • Taoyuan City, Taiwan
        Chang Gung Memorial Hospital
      Feb 21, 2023

      Cancer Pain, Tumor, Solid, Carcinoma Trial in Xinxiang (PCA pump)

      Not yet recruiting
      • Cancer Pain
      • +2 more
      • PCA pump
      • Xinxiang, Henan, China
        The First Affiliated Hospital of Xinxiang Medical University
      Feb 24, 2023

      Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

      Not yet recruiting
      • Cancer
      • +16 more
      • KVA12123 - Dose Escalation
      • +3 more
      • (no location specified)
      Feb 2, 2023

      Carcinoma Trial in Worldwide (osimertinib, savolitinib, )

      Recruiting
      • Carcinoma
      • La Jolla, California
      • +95 more
      Feb 1, 2023

      Blood and Urine From Patients Undergoing Radiation Therapy

      Enrolling by invitation
      • Carcinoma
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 26, 2023

        Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

        Active, not recruiting
        Has Results
        • Carcinoma
        • +7 more
        • La Jolla, California
        • +58 more
        Jan 13, 2023

        Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

        Completed
        Has Results
        • Carcinoma
        • Renal Cell
        • London, United Kingdom
          Pfizer UK
        Jan 9, 2023

        Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)

        Not yet recruiting
        • Gynecologic Cancer
        • +3 more
        • Cabo + Dostarlimab
        • Birmingham, Alabama
          O'Neal Comprehensive Cancer Center at UAB
        Jan 10, 2023

        Carcinoma, Sleep Disorder Trial in China (Yangzheng Compound Mixture, Conventional Treatment)

        Recruiting
        • Carcinoma
        • Sleep Disorder
        • Yangzheng Compound Mixture
        • Conventional Treatment
        • Chongqing, Chongqing, China
        • +9 more
        Dec 27, 2022

        Melanoma (Skin), Carcinoma Trial in Copenhagen (Dermloop Learn)

        Completed
        • Melanoma (Skin)
        • Carcinoma
        • Dermloop Learn
        • Copenhagen, Danmark, Denmark
          AISC Research Fascility
        Dec 13, 2022

        Carcinoma, Non-Small-Cell Lung Trial in Worldwide (Lorlatinib)

        Recruiting
        • Carcinoma
        • Non-Small-Cell Lung
        • Orange, California
        • +31 more
        Dec 6, 2022